创新医疗:2025一季报净利润-0.14亿 同比下降366.67%

Financial Performance - The company reported a basic earnings per share of -0.0300 yuan for Q1 2025, a decrease of 347.76% compared to -0.0067 yuan in Q1 2024 [1] - Net profit for Q1 2025 was -0.14 billion yuan, representing a significant decline of 366.67% from -0.03 billion yuan in Q1 2024 [1] - Operating revenue decreased by 3.98% to 1.93 billion yuan in Q1 2025, down from 2.01 billion yuan in Q1 2024 [1] - The return on equity was -0.79% in Q1 2025, a drop of 393.75% from -0.16% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 15,020.82 million shares, accounting for 36.07% of the circulating shares, with a decrease of 302.26 million shares compared to the previous period [2] - The largest shareholder, Chen Xiaying, holds 7,761.70 million shares, representing 18.64% of the total share capital, with no change [3] - Shanghai Guanghuan Technology Co., Ltd. holds 3,372.02 million shares (8.10%), unchanged from the previous period [3] - Hangzhou Changjian Investment Partnership (Limited Partnership) decreased its holdings by 392.00 million shares to 1,814.42 million shares (4.36%) [3] Dividend Policy - The company has decided not to distribute dividends or transfer shares in this period [3]